- 商品介绍
- 规格参数
- 包装参数
产品介绍
Product Description
Biochem/physiol Actions
A192621 is a selective; orally available ETB endothelin receptor antagonist. A192621 has been shown to cause an increase in arterial blood pressure and to promote apoptosis in human pulmonary arterial smooth muscle cells.
Selective; orally available ETB endothelin receptor antagonist
技术参数
Specifications
| assay | ≥98% (HPLC) |
| form | powder |
| color | white to beige |
| solubility | DMSO: 2 mg/mL, clear |
| web metadata keyword.default | (2R,3R,4S)-4-(1,3-Benzodioxol-5-yl)-1-[2-[(2,6-diethylphenyl)amino]-2-oxoethyl]-2-(4-propoxyphenyl)-3-pyrrolidinecarboxylic acid for research,A192621 arterial blood pressure research,A192621 chemical structure and properties,A192621 endothelin antagonist in vitro studies,A192621 endothelin receptor antagonist dosage,A192621 endothelin receptor antagonist,A192621 for apoptosis studies,A192621 for pulmonary arterial smooth muscle cells,A192621 lab-grade endothelin receptor antagonist,A192621 product specifications and applications,A192621 research chemical,A192621 selective ETB antagonist,A192621,Sigma-Aldrich A192621 procurement |
| storage temp. | −20°C |
| SMILES string | O=C(NC1=C(CC)C=CC=C1CC)CN(C[C@H](C2=CC3=C(OCO3)C=C2)[C@H]4C(O)=O)[C@H]4C5=CC=C(OCCC)C=C5 |
| InChI | 1S/C33H38N2O6/c1-4-16-39-25-13-10-23(11-14-25)32-30(33(37)38)26(24-12-15-27-28(17-24)41-20-40-27)18-35(32)19-29(36)34-31-21(5-2)8-7-9-22(31)6-3/h7-15,17,26,30,32H,4-6,16,18-20H2,1-3H3,(H,34,36)(H,37,38)/t26-,30-,32+/m1/s1 |
| InChI key | LQEHCKYYIXQEBM-FUKIBTTHSA-N |
| 长度(mm) | |
| 宽度(mm) | |
| 高度(mm) | |
| 重量(kg) |
猜你喜欢
-
询价
-
询价
-
¥ 625.35
-
¥ 521.16
-
¥ 711.69
-
¥ 3317.36
-
¥ 2355.14
-
询价
-
询价
-
询价
-
询价
-
询价
-
询价
-
¥ 782.57
-
¥ 3254.04
-
询价
-
¥ 1153.44
-
询价
-
¥ 1604.79
-
¥ 1361.98
微信小程序
7X24小时在线咨询